Antibiotic effectiveness can be restored if utilized in the correct combination with each other, non-antibiotic adjuvants or even food additives.
Browsing: Clinical > Antimicrobial Resistance
The US FDA has approved Zemdri for use in adults with complicated urinary tract infections; however, the agency has also issued a response for bloodstream infections noting there isn’t substantial evidence of Zemdri’s effectiveness.
Researchers have discovered a high prevalence of colistin-resistant E. coli in the Vietnamese town of Nguyen Xa, according to research presented at ASM Microbe.
An isolate of colistin-heteroresistant, carbapenem-resistant, hypervirulent/hypermucoviscous Klebsiella pneumoniae has been identified in the USA.
In research presented at ASM Microbe a team have delved into the dynamics of E. coli in urban streams in the USA, indicating possible antibiotic resistance activity.
A study presented at ASCO this weekend has suggested that antibiotic use greatly reduces the progression-free survival and overall survival of cancer patients receiving immunotherapy.
The UK government will commit more than £30 million towards funding research against antimicrobial resistance.
In our latest interview, we spoke to Jean-Pierre Paccaud, Director of Business Development & Corporate Strategy at GARDP, about the drug developer’s model and his thoughts on the wider field.
Trends in Acinetobacter baumannii infections, one of the most prevalent hospital-acquired infections in children, have been studied revealing that both cephalosporin and carbapenem resistance has increased.
Take a look behind the science of a recent Future Microbiology article, entitled ‘Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis’ as we ask the authors about the challenges currently facing multidrug resistant (MDR) tuberculosis and what the future might hold.